On (b)(6) 2020, a 35mm amplatzer cribriform occluder was selected for implant in a patient with a multifenestrated asd.The physician proceeded to complete the procedure according to the ifu, but after the device was deployed a small shunt across the septum was noted through tee.The physician decided to retract the device and remove the device from the patient.Once the 35 mm amplatzer cribriform occluder was removed it was found to have what appeared to be a clot on the device.The physician ordered additional heparin and rechecked the act.The act was confirmed at 270.A new 35 mm amplatzer cribriform occluder was selected for implant and through tee it was confirmed to have successfully occluded the multifenestrated asd.The patient remained hemodynamically stable throughout the procedure and there was no clinically significant delay in procedure.
|
Additional information for: d10, g4, g7, h2, h3, h6, and h10.Corrected information for: h6.An event of residual shunt and thrombus was reported.The investigation confirmed the device met dimensional specifications when analyzed at abbott.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The cause of the reported event remains unknown.
|